Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Prostate|February 18, 2004
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin AAlessandro Sciarra, Giuseppe Voria, Salvatore Monti, et al.
European Urology|February 5, 2003
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysisFranco Di Silverio, Vincenzo Gentile, Anna De Matteis, et al.
The Prostate|April 15, 2003
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinomaAlessandro Sciarra, Salvatore Monti, Vincenzo Gentile, et al.
European Urology|April 11, 2007
Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case reportAlessandro Sciarra, Ana Maria Autran Gomez, Alessandro Gentilucci, et al.
Urology|November 16, 2005
Chromogranin A expression in familial versus sporadic prostate cancerAlessandro Sciarra, Salvatore Monti, Vincenzo Gentile, et al.
Urologia Internationalis|March 26, 2008
Long-term experience with an anatomical anterograde approach to radical prostatectomy: results in terms of positive margin rateAlessandro Sciarra, Vincenzo Gentile, Anna De Matteis, et al.
European Urology|January 30, 2008
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancerAlessandro Sciarra, Valeria Panebianco, Stefano Salciccia, et al.
European Radiology|July 25, 2008
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlationValeria Panebianco, Alessandro Sciarra, Marcello Osimani, et al.
European Urology|February 24, 2007
Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: magnetic resonance imaging with 1H-spectroscopyAlessandro Sciarra, Valeria Panebianco, Mauro Ciccariello, et al.
Urologia|May 17, 2011
[Neuroendocrine target therapies for prostate cancer]Alessandro Sciarra, Michele Innocenzi, Michele Ravaziol, et al.
Pageof 5